查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1808916

弓形蟲病檢測市場，按產品類型、按檢測類型、按技術、按樣本類型、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Toxoplasmosis Testing Market, By Product Type, By Test Type, By Technology, By Sample Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 398 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年弓形蟲病檢測市場規模價值 12.67 億美元，2025 年至 2032 年的複合年成長率為 9.1%。

弓形蟲病檢測市場涉及檢測弓形蟲感染的診斷程序，主要透過血清學和分子檢測。市場成長的動力源自於免疫功能低下患者、孕婦和器官移植接受者中弓形蟲病病例的增加，尤其是在衛生條件和意識薄弱的地區。產前篩檢計畫的興起（尤其是在歐洲和南美洲）以及核酸擴增檢測 (NAAT) 在診斷實驗室中的應用正在提振需求。然而，市場也面臨諸如漏報、公共衛生監測不足以及低收入地區檢測實務不一致等限制因素。在機會方面，不斷成長的研發資金、PCR 和 ELISA 平台的技術改進以及診斷公司與公共衛生機構（例如美國疾病管制與預防中心和世界衛生組織）之間的合作預計將在未來幾年支持市場擴張。

弓形蟲病檢測市場-市場動態

產前篩檢和診斷技術的進步推動弓形蟲病檢測市場成長

由於人們越來越重視產前護理和傳染病管理，弓形蟲病檢測市場發展勢頭強勁。根據美國疾病管制與預防中心 (CDC) 統計，美國有超過 4,000 萬人感染弓形蟲病，但大多數患者沒有症狀。孕婦和免疫功能低下者尤其容易感染，因此法國、奧地利和巴西等國家製定了定期篩檢方案。 2023 年，歐洲疾病預防控制中心 (ECDC) 強調，東歐正在加強宣傳活動並改善診斷方法，以減少先天性感染。同時，世界衛生組織 (WHO) 在食源性寄生蟲疾病方面的努力也促進了公共衛生策略的改進，尤其是在發展中國家。診斷實驗室和醫院之間日益加強的合作，例如在公共衛生診所進行標準化血清學檢測，也促進了市場擴張。

弓形蟲病檢測市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 9.1%。

根據產品類型細分，預計檢測試劑盒將在 2024 年佔據最大市場佔有率

根據檢測類型細分，血清學檢測是 2024 年的主要檢測類型

根據技術細分，酵素連結免疫吸附試驗 (ELISA) 是 2024 年的領先技術

根據樣本類型細分，血液是 2024 年的主要樣本類型

根據最終用戶細分，醫院是 2024 年的主要最終用戶

按地區分類，北美是 2024 年的主要收入來源

弓形蟲病檢測市場-細分分析：

全球弓形蟲病檢測市場根據產品類型、檢測類型、技術、樣本類型、最終用戶和地區進行細分。

根據產品類型，市場分為四類：檢測試劑盒、試劑、儀器和分析儀以及軟體解決方案。檢測試劑盒因其在臨床和即時診斷中的廣泛應用而佔據最高優先級。試劑緊隨其後，受持續性需求的推動。儀器和分析儀排名第二，而軟體解決方案在結果解讀中發揮著支持性但新興的作用。

根據檢測類型，市場分為三類：血清學檢測、分子檢測、組織學檢測和其他。血清學檢測因其成本效益高且臨床應用廣泛而佔據市場主導地位。分子檢測緊隨其後，其在參考實驗室的應用日益增加。組織學檢測的受歡迎程度較低，而其他類型的檢測市佔率則微乎其微。

弓形蟲病檢測市場-地理洞察

在歐洲，法國和奧地利等國家已實施常規產前弓形蟲病篩檢計劃，顯著提高了早期診斷率並推動了市場發展。根據歐洲疾病預防控制中心 (ECDC) 的數據，先天性弓形蟲病仍然是公共衛生策略的重點，尤其是在感染率較高的東歐。在北美，美國疾病管制與預防中心 (CDC) 與公共衛生部門和診斷實驗室合作，提高對孕婦和免疫功能低下人群的認知並進行預防性檢測。在巴西，衛生部在其先天性感染控制計畫下加強了弓形蟲病監測，提高了公立醫院診斷服務的可近性。據報道，2024 年，巴西和阿根廷的大學醫院與診斷試劑供應商合作，以推進在地化血清學研發。這些針對特定地區的措施和機構聯盟正在穩步促進全球醫療體系對弓形蟲病的檢測和控制。

弓形蟲病檢測市場-競爭格局：

弓形蟲病檢測市場競爭適中，多家診斷公司和研究機構致力於提高檢測靈敏度和可負擔性。 Bio-Rad Laboratories、雅培和DiaSorin等主要參與者正與學術機構和公共衛生機構合作，持續推動血清學檢測方法的開發。 2024年，DiaSorin與米蘭大學合作，改進IgG親和力檢測，以便在懷孕早期檢測弓形蟲病。同樣，巴斯德研究所與法國的診斷新創公司合作，支持資源匱乏地區的快速檢測試劑盒創新。同時，雅培擴展了其分子診斷部門，整合了病原體特異性PCR平台，以涵蓋包括弓形蟲在內的寄生蟲感染。在區域層面，巴西的Fiocruz公司與當地生物技術公司合作生產ELISA檢測試劑盒，以減少對進口診斷試劑的依賴。此類策略聯盟和公私合作夥伴關係正在加強全球檢測基礎設施，並加速採用更高效的弓形蟲病診斷方法。

最新動態：

2024年5月，芝加哥大學和LDBIO Diagnostics公司推出了一種快速即時檢測方法－弓形蟲ICT IgG-IgM，只需刺破手指，30分鐘內即可進行準確檢測，靈敏度超過97.5%，特異性達到100%，有效降低假陽性率，提高產前篩檢準確度。

2025 年 5 月，海得拉巴國家動物生物技術研究所 (NIAB) 的科學家利用基於 CRISPR 的基因操作技術精確定位了一種弓形蟲蛋白，這種蛋白可能是預防人畜共患疾病傳播和先天性弓形蟲病的關鍵——這項工作與世界衛生組織和糧農組織在食源性寄生蟲病糧農組織方面的優先事項相一致。

目錄

第1章：弓形蟲病檢測市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 弓漿蟲病檢測市場片段（依產品類型）
    • 弓漿蟲病檢測市場片段（依檢測類型）
    • 弓漿蟲病檢測市場（依技術）
    • 弓漿蟲病檢測市場片段（依樣本類型）
    • 弓形蟲病檢測市場片段（按最終用戶）
    • 弓形蟲病檢測市場（按國家/地區）
    • 弓形蟲病檢測市場（按地區）
  • 競爭洞察

第3章：弓形蟲病檢測主要市場趨勢

  • 弓形蟲病檢測市場促進因素
    • 市場促進因素的影響分析
  • 弓形蟲病檢測市場限制
    • 市場限制的影響分析
  • 弓形蟲病檢測市場機遇
  • 弓形蟲病檢測市場未來趨勢

第4章：弓形蟲病檢測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：弓形蟲病檢測市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：弓形蟲病檢測市場格局

  • 2024年弓漿蟲病檢測市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：弓形蟲病檢測市場－依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 測試套件
    • 試劑
    • 儀器和分析儀
    • 軟體解決方案

第8章：弓形蟲病檢測市場－依檢測類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 血清學檢測
    • 分子檢測
    • 組織學檢查
    • 其他

第9章：弓形蟲病檢測市場－按技術

  • 概述
    • 按技術細分的市場佔有率分析
    • 酵素連結免疫吸附試驗（ELISA）
    • 聚合酶鍊式反應（PCR）
    • 其他

第10章：弓形蟲病檢測市場－依樣本類型

  • 概述
    • 依樣本類型進行細分佔有率分析
    • 血
    • 羊水
    • 腦脊髓液
    • 其他體液

第 11 章：弓形蟲病檢測市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院
    • 診斷實驗室
    • 研究機構
    • 家庭護理設置

第 12 章：弓形蟲病檢測市場 - 按地域分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美弓形蟲病檢測主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按樣本類型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲弓形蟲病檢測主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模及預測（依樣本類型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區弓形蟲病檢測主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品類型）
    • 亞太地區市場規模及預測（依測試類型）
    • 亞太地區市場規模及預測（依技術）
    • 亞太地區市場規模及預測（依樣本類型）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲弓形蟲病檢測主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依產品類型）
    • 拉丁美洲市場規模及預測（按測試類型）
    • 拉丁美洲市場規模及預測（按技術）
    • 拉丁美洲市場規模及預測（依樣本類型）
    • LATAM 規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲弓形蟲病檢測主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按測試類型）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按樣本類型）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 13 章：弓形蟲病檢測產業主要供應商分析

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Abbott Laboratories
    • ARUP Laboratories
    • Becton, Dickinson and Company
    • bioMerieux
    • Bio-Rad Laboratories
    • Creative Diagnostics
    • Danaher Corporation
    • DiaSorin
    • F. Hoffmann-La Roche
    • Luminex Corporation
    • NovaTec Immundiagnostica
    • Omega Diagnostics
    • Ortho Clinical Diagnostics
    • QIAGEN
    • Randox Laboratories
    • Siemens Healthineers
    • Thermo Fisher Scientific
    • Trinity Biotech
    • Vircell
    • ZEUS Scientific
    • Others

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5567

Toxoplasmosis Testing Market size was valued at US$ 1,267 Million in 2024, expanding at a CAGR of 9.1% from 2025 to 2032.

The Toxoplasmosis Testing Market involves diagnostic procedures to detect Toxoplasma gondii infection, primarily through serological and molecular tests. Market growth is driven by increasing cases of toxoplasmosis in immunocompromised patients, pregnant women, and organ transplant recipients, especially in regions with limited sanitation and awareness. Rising prenatal screening initiatives, particularly in Europe and South America, and the use of nucleic acid amplification tests (NAATs) in diagnostic labs are bolstering demand. However, the market faces restraints such as underreporting, limited public health surveillance, and inconsistent testing practices in low-income regions. On the opportunity front, growing R&D funding, technological improvements in PCR and ELISA platforms, and collaborations between diagnostic companies and public health agencies (e.g., CDC and WHO) are expected to support market expansion over the coming years.

Toxoplasmosis Testing Market- Market Dynamics

Rising Prenatal Screening and Diagnostic Advancements Fuel Toxoplasmosis Testing Market Growth

The toxoplasmosis testing market is gaining momentum due to the increasing emphasis on prenatal care and infectious disease management. According to the CDC, toxoplasmosis affects over 40 million people in the U.S., though most remain asymptomatic. Pregnant women and immunocompromised individuals are particularly at risk, prompting regular screening protocols in countries like France, Austria, and Brazil. In 2023, the European Centre for Disease Prevention and Control (ECDC) highlighted rising awareness campaigns and improved diagnostics in Eastern Europe to reduce congenital infections. Simultaneously, initiatives like the WHO's efforts on foodborne parasitic diseases have led to improved public health strategies, especially in developing nations. Growing collaborations between diagnostic labs and hospitals, such as standardized serological testing in public health clinics, are also contributing to market expansion.

Toxoplasmosis Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2025-2032)

Based on product type segmentation, Test kits were predicted to show maximum market share in the year 2024

Based on Test Type segmentation, Serological tests were the leading Test Type in 2024

Based on Technology segmentation, Enzyme-Linked Immunosorbent Assay (ELISA) was the leading Technology in 2024

Based on Sample Type segmentation, Blood was the leading Sample Type in 2024

Based on end user segmentation, Hospitals were the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Toxoplasmosis Testing Market- Segmentation Analysis:

The Global Toxoplasmosis Testing Market is segmented on the basis of Product Type, Test Type, Technology, Sample Type, End User, and Region.

The market is divided into four categories based on product type: Test Kits, Reagents, Instruments and Analyzers, and Software Solutions. Test kits held the highest priority due to their widespread use in clinical and point-of-care diagnostics. Reagents followed, driven by recurring demand. Instruments and analyzers ranked next, while software solutions held a supportive yet emerging role in result interpretation.

The market is divided into three categories based on Test Type: Serological Tests, Molecular Tests, Histological Tests, and Other. Serological tests led the market due to their cost-effectiveness and broad clinical use. Molecular tests followed closely with rising adoption in reference labs. Histological tests were less preferred, while other test types held minimal market share.

Toxoplasmosis Testing Market- Geographical Insights

In Europe, countries such as France and Austria have implemented routine prenatal toxoplasmosis screening programs, significantly boosting early diagnosis and driving market development. According to the European Centre for Disease Prevention and Control (ECDC), congenital toxoplasmosis remains a critical focus in public health strategies, especially in Eastern Europe, where infection rates are higher. In North America, the CDC promotes awareness and preventive testing among pregnant women and immunocompromised individuals, supported by collaborations with public health departments and diagnostic labs. In Brazil, the Ministry of Health has strengthened toxoplasmosis surveillance under its congenital infection control program, enhancing access to diagnostic services in public hospitals. In 2024, collaborations between university hospitals and diagnostic reagent providers were reported in Brazil and Argentina to advance localized serology development. These region-specific initiatives and institutional alliances are steadily contributing to the improved detection and control of toxoplasmosis across global healthcare systems.

Toxoplasmosis Testing Market- Competitive Landscape:

The toxoplasmosis testing market is moderately competitive, with several diagnostic firms and research institutions focused on enhancing test sensitivity and affordability. Key players like Bio-Rad Laboratories, Abbott, and DiaSorin continue to advance serological assay development in collaboration with academic and public health institutions. In 2024, DiaSorin partnered with the University of Milan to refine IgG avidity testing for early toxoplasmosis detection in pregnancy. Similarly, the Pasteur Institute has collaborated with diagnostic startups in France to support rapid test kit innovation for low-resource settings. Meanwhile, Abbott expanded its molecular diagnostics division by integrating pathogen-specific PCR platforms to cover parasitic infections, including T. gondii. On the regional level, Brazil's Fiocruz has worked with local biotech firms to produce ELISA test kits, reducing reliance on imported diagnostics. Such strategic alliances and public-private partnerships are strengthening the global testing infrastructure and accelerating the adoption of more efficient toxoplasmosis diagnostics.

Recent Developments:

In May 2024, the University of Chicago and LDBIO Diagnostics introduced a rapid point-of-care test, the Toxoplasma ICT IgG-IgM, offering accurate detection within 30 minutes from a finger-prick, with over 97.5% sensitivity and 100% specificity, effectively reducing false positives and improving prenatal screening accuracy.

In May 2025, scientists at the National Institute of Animal Biotechnology (NIAB) in Hyderabad used CRISPR-based genetic manipulation to pinpoint a Toxoplasma gondii protein that could be key in preventing zoonotic transmission and congenital toxoplasmosis-an effort aligned with WHO and FAO priorities on foodborne parasitic diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TOXOPLASMOSIS TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • ARUP Laboratories
  • Becton, Dickinson and Company
  • bioMerieux
  • Bio-Rad Laboratories
  • Creative Diagnostics
  • Danaher Corporation
  • DiaSorin
  • F. Hoffmann-La Roche
  • Luminex Corporation
  • NovaTec Immundiagnostica
  • Omega Diagnostics
  • Ortho Clinical Diagnostics
  • QIAGEN
  • Randox Laboratories
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Trinity Biotech
  • Vircell
  • ZEUS Scientific
  • Others

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Test Kits
  • Reagents
  • Instruments and Analyzers
  • Software Solutions

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Serological Tests
  • Molecular Tests
  • Histological Tests
  • Other

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR)
  • Others

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Blood
  • Amniotic Fluid
  • Cerebrospinal Fluid
  • Other

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions
  • Homecare Settings

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Toxoplasmosis Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Toxoplasmosis Testing Market Snippet by Product Type
    • 2.1.2. Toxoplasmosis Testing Market Snippet by Test Type
    • 2.1.3. Toxoplasmosis Testing Market Snippet by Technology
    • 2.1.4. Toxoplasmosis Testing Market Snippet by Sample Type
    • 2.1.5. Toxoplasmosis Testing Market Snippet by End User
    • 2.1.6. Toxoplasmosis Testing Market Snippet by Country
    • 2.1.7. Toxoplasmosis Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Toxoplasmosis Testing Key Market Trends

  • 3.1. Toxoplasmosis Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Toxoplasmosis Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Toxoplasmosis Testing Market Opportunities
  • 3.4. Toxoplasmosis Testing Market Future Trends

4. Toxoplasmosis Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Toxoplasmosis Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Toxoplasmosis Testing Market Landscape

  • 6.1. Toxoplasmosis Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Toxoplasmosis Testing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Test Kits
    • 7.1.3. Reagents
    • 7.1.4. Instruments and Analyzers
    • 7.1.5. Software Solutions

8. Toxoplasmosis Testing Market - By Test Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 8.1.2. Serological Tests
    • 8.1.3. Molecular Tests
    • 8.1.4. Histological Tests
    • 8.1.5. Other

9. Toxoplasmosis Testing Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 9.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 9.1.3. Polymerase Chain Reaction (PCR)
    • 9.1.4. Others

10. Toxoplasmosis Testing Market - By Sample Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
    • 10.1.2. Blood
    • 10.1.3. Amniotic Fluid
    • 10.1.4. Cerebrospinal Fluid
    • 10.1.5. Other Body Fluids

11. Toxoplasmosis Testing Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Diagnostic Laboratories
    • 11.1.4. Research Institutions
    • 11.1.5. Homecare Settings

12. Toxoplasmosis Testing Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Toxoplasmosis Testing Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Toxoplasmosis Testing Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Toxoplasmosis Testing Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Toxoplasmosis Testing Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Toxoplasmosis Testing Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Toxoplasmosis Testing Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. ARUP Laboratories
    • 13.2.3. Becton, Dickinson and Company
    • 13.2.4. bioMerieux
    • 13.2.5. Bio-Rad Laboratories
    • 13.2.6. Creative Diagnostics
    • 13.2.7. Danaher Corporation
    • 13.2.8. DiaSorin
    • 13.2.9. F. Hoffmann-La Roche
    • 13.2.10. Luminex Corporation
    • 13.2.11. NovaTec Immundiagnostica
    • 13.2.12. Omega Diagnostics
    • 13.2.13. Ortho Clinical Diagnostics
    • 13.2.14. QIAGEN
    • 13.2.15. Randox Laboratories
    • 13.2.16. Siemens Healthineers
    • 13.2.17. Thermo Fisher Scientific
    • 13.2.18. Trinity Biotech
    • 13.2.19. Vircell
    • 13.2.20. ZEUS Scientific
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us